- Dr Reddy's to restructure German subsi Betapharm
Pharma major Dr Reddy's Laboratories (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in the future.
23 Jul, 2010, 09.57 PM IST
- No plan to sell domestic formulations business: Dr Reddy's
Pharma major Dr Reddy's Laboratories Ltd (DRL) on Friday said it was restructuring German subsidiary Betapharm for better results in future...
23 Jul, 2010, 09.25 PM IST
- Dr Reddy's nets Rs 167 crore in Q4
Dr Reddy’s Laboratories bounced back into profit for the three months ended March, helped by the absence of any further provisioning for lo...
07 May, 2010, 01.37 AM IST
- Non-regulated markets, leverage to pep up growth
At Rs 860 crore, the one-time write-off of goodwill of Dr Reddy's Laboratories' German subsidiary, Betapharm, has severely impacted its con...
21 Jan, 2010, 11.57 AM IST
- Growth in US, local market to pep up DRL
Dr Reddy’s Laboratories (DRL), India’s third-largest pharma company, has seen a sharp rise of 25% in its stock price over the past fifteen ...
03 Oct, 2009, 12.38 AM IST
- Reddy's (betapharm) receives preliminary results on AOK tender in Germany
The tender procedure is yet to be concluded and is expected to face the potential legal objections by several companies.
10 Dec, 2008, 12.57 PM IST
- Pricing pressure in US, Germany hits DRL profit
Dr Reddy’s Laboratories (DRL), country’s second-largest pharma company in terms of sales, has reported a worst-than-expected drop of 51% in...
24 Oct, 2008, 04.32 AM IST
- Dr Reddy's could face margin pressure in Germany
Leading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...
13 Oct, 2008, 07.16 PM IST
- DRL describes Ranbaxy, Daiichi deal as path breaking
Dr Reddy's Laboratory, which defeated Ranbaxy in acquiring German company Betapharm, today said the Ranbaxy-Daiichi deal is "path breaking".
11 Jun, 2008, 07.52 PM IST
- Dr Reddy's plans to file 20 new drug applications
Dr Reddy’s Laboratories is betting on the US market and plans to file about 20 more ANDAs (Abbreviated New Drug Applications) in 2008. Reso...
02 Feb, 2008, 10.00 AM IST
- DRL bets on India plan for German arm
Dr Reddy’s Laboratories (DRL) aims to shift production of about a dozen top-selling products of its German arm Betapharm to India by July 2...
24 Dec, 2007, 04.31 AM IST
- Dr Reddy's in race for US Par Pharma
Dr Reddy’s Laboratories is in the race with three other Indian drug majors to acquire US-based generic drug maker Par Pharma.
02 Oct, 2007, 03.26 AM IST
- After strong Q1, Ranbaxy reclaims numero uno slot
Ranbaxy has reclaimed the top slot as the largest pharma company in India from Dr Reddy’s Laboratories.
27 Jul, 2007, 02.40 AM IST
- Dr Reddy's gets a shot in the arm
Dr Reddy’s Laboratories’ performance in FY07 has got a boost from selling authorised generics and revenues from its various acquisitions.
23 May, 2007, 02.48 AM IST
- Bumps ahead on M&A street
Indian companies will look for bigger acquisition opportunities in the New Year spurred by rising economic growth.
29 Dec, 2006, 03.19 AM IST
- DRL can use ADS mop-up to slash debt, fund acquisitions
Dr Reddy’s Labs’ ADS issue could allow the domestic pharmaceutical major to raise around $235m (Rs 1,060 crore), taking into consideration ...
16 Nov, 2006, 12.57 AM IST
- Dr Reddy's plans fund raising from overseas market
Hyderabad-based drugmaker Dr Reddy's is planning to raise funds from overseas market to finance its inorganic growth strategy.
28 Aug, 2006, 04.58 PM IST